The Value of Infectious Diseases Consultation in Staphylococcus Aureus Bacteremia
Overview
Affiliations
Background: Staphylococcus aureus bacteremia results in substantial mortality. Infectious diseases specialist consultation can improve adherence to evidence-based management of S. aureus bacteremia, but its effect on mortality is unclear.
Methods: A 2-year prospective cohort study of patients with S. aureus bacteremia was performed at a large tertiary care hospital. Patients who died within 2 days of diagnosis were excluded. Independent risk factors for 28-day mortality were determined.
Results: Among 341 patients with S. aureus bacteremia, 189 (55%) were male, 196 (58%) were Caucasian, 185 (54%) had methicillin-resistant S. aureus, 108 (32%) had nosocomial bacteremia, and 231 (68%) had a central venous catheter at the time of diagnosis. The median age was 56 years (range 22-95 years). A total of 111 patients (33%) had an infectious diseases consultation. Fifty-four patients (16%) died within 28 days after diagnosis. Factors associated with mortality were intensive care unit admission 48 hours or less after the first positive blood culture (adjusted hazard ratio, 4.65; 95% confidence interval [CI], 2.65-8.18), cirrhosis (adjusted hazard ratio, 4.44; 95% CI, 2.40-8.20), and advanced age (adjusted hazard ratio, 1.27 per every 10 years of age; 95% CI, 1.08-1.50). Infectious diseases consultation was associated with a 56% reduction in 28-day mortality (adjusted hazard ratio, 0.44; 95% CI, 0.22-0.89).
Conclusion: Only one third of patients with S. aureus bacteremia in this cohort had an infectious diseases specialist consultation. Infectious diseases consultation was independently associated with a reduction in 28-day mortality. Routine infectious diseases consultation should be considered for patients with S. aureus bacteremia, especially those with greater severity of illness or multiple comorbidities.
Current management of bacteremia in a Japanese university hospital.
Hanai S, Yokose M, Harada Y, Doi Y, Shimizu T Fujita Med J. 2024; 10(4):106-110.
PMID: 39494439 PMC: 11528325. DOI: 10.20407/fmj.2024-010.
Naureckas Li C, Patel S, Collins C Pediatr Cardiol. 2024; .
PMID: 39134676 DOI: 10.1007/s00246-024-03616-4.
Westgeest A, Lambregts M, Ruffin F, Korn R, Webster M, Kair J JAMA Netw Open. 2024; 7(2):e240473.
PMID: 38411961 PMC: 10900971. DOI: 10.1001/jamanetworkopen.2024.0473.
A Needs Assessment for Infectious Diseases Consultation in Community Hospitals.
Hollingshead C, Khazan A, Franco J, Ciricillo J, Haddad M, Berry J Infect Dis Ther. 2023; 12(6):1725-1737.
PMID: 37243912 PMC: 10221748. DOI: 10.1007/s40121-023-00810-4.
Marcelin J, Keintz M, Ma J, Van Schooneveld T, Alexander B, Bergman S Antimicrob Steward Healthc Epidemiol. 2023; 3(1):e48.
PMID: 36970426 PMC: 10031584. DOI: 10.1017/ash.2023.132.